Calcineurin Inhibitors: all 995 studies that test it
Page 1 of 10. Open to participants first (83), then studies with results posted, then the rest; newest registration first within each.
- Osimertinib and Cyclosporine A to Enhance Antitumor Efficacy in NSCLCRecruitingNCT07874490Phase 2
- A Study to Investigate the Effect of Omeprazole and Cyclosporine on Velzatinib in Healthy ParticipantsNot yet recruitingNCT07862114Phase 1
- Tacrolimus as Prophylaxis of Post-ERCP PancreatitisNot yet recruitingNCT07781722Phase 4
- Automated Total Marrow and Lymphoid Irradiation for Allogeneic Hematopoietic Cell TransplantNot yet recruitingNCT07634536Phase 2
- A Phase 3 Study of Extended-release Tacrolimus in Subjects With Pulmonary Arterial Hypertension and Functional LimitationsNot yet recruitingNCT07612657Phase 3
- Cord Blood Transplantation in Children and Young Adults With Blood CancerRecruitingNCT07566377Phase 2
- CsA+EPAG/HPAG+Romiplostim N01 in Newly-diagnosed SAA/TD-NSAANot yet recruitingNCT07558434Phase 2
- Vevye + Flarex Combination Therapy for Dry EyeEnrolling by invitationNCT07553455Phase 4
- Stem Cell Transplantation for Participants With Germline RUNX1 Associated Blood CancersNot yet recruitingNCT07524530Phase 2
- A Randomized Controlled Trial Comparing the Effectiveness and Safety of Topical Tacrolimus 0.03% Versus Crisaborole 2% in Patients With Mild to Moderate Atopic Dermatitis Over 8 WeeksNot yet recruitingNCT07519174Not applicable
- Comparative Evaluation of the Safety and Effectiveness of Crisaborole Ointment (2%) Versus Tacrolimus Ointment (0.1%) for the Topical Treatment of Atopic DermatitisNot yet recruitingNCT07437534Phase 4
- A Study on the Efficacy and Safety of JAK Inhibitors Versus Calcineurin Inhibitors as Initial Therapy for Interstitial Lung Disease Associated With Antisynthetase SyndromeRecruitingNCT07406932Not applicable
- Cyclosporine Or Methotrexate for Pediatric Alopecia Areata: Routine Clinical Care Effectiveness StudyRecruitingNCT07381556Phase 4
- Comparison of Conjunctival Goblet Cell Density in Dry Eye Patients Treated With Cyclosporine 0.1% Dissolved in Perfluorobutylpentane (Vevye®) or Generic 0.05% Cyclosporine Emulsion for 8 WeeksNot yet recruitingNCT07368595Phase 4
- Co-infusion of Treg-enriched Donor Lymphocytes With CD3-depleted Hematopoietic Stem Cell Graft to Prevent Graft-versus Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation Among Children With Hematologic MalignanciesRecruitingNCT07366801Phase 2/3
- Utilization of a Microdevice for Psoriasis and Atopic DermatitisNot yet recruitingNCT07352566Phase 4
- TACrolimus Targeted Immunosuppression Cessation in ALlogeneic HCTRecruitingNCT07302776Phase 1
- Tacrolimus Ophthalmic Solution for the Treatment of Non-infectious Anterior UveitisRecruitingNCT07285070Phase 2
- Dose-Expansion Study of Low Dose Post-Transplant Cyclophosphamide/Tacrolimus/Ruxolitinib for Graft-versus-Host Disease (GVHD) Prophylaxis in Myeloablative Allogeneic Peripheral Blood Stem Cell TransplantationRecruitingNCT07249346Phase 2
- Efficacy of Vevye Ophthalmic Solution for the Treatment of Meibomian Gland DysfunctionRecruitingNCT07224529Phase 4
- Use of Tacrolimus and MTOR Inhibitors With Anticipatory Therapy vs. Tacrolimus and Mycophenolic Acid With Universal Prophylaxis in Renal Recipients at High Risk of Posttransplant Cytomegalovirus.Not yet recruitingNCT07203664Phase 4
- Crisaborole 2% Versus Tacrolimus 0.1% in Children With Mild to Moderate Atopic DermatitisNot yet recruitingNCT07162896Phase 3
- Immunosuppressant Management in Rheumatology Patients Undergoing Elective Total Shoulder ArthroplastyRecruitingNCT07138898Phase 2
- Tacrolimus Eye Drops in Treatment of Vernal KeratoconjunctivitisNot yet recruitingNCT07138742Not applicable
- A Study to Learn More About the Effects and Safety of JMT601 in Adults With Primary Membranous NephropathyNot yet recruitingNCT07029139Phase 2
- Emapalumab With Post-Transplant Cyclophosphamide, Tacrolimus and Mycophenolate Mofetil for the Prevention of Graft-versus-Host Disease After Donor Reduced-Intensity Hematopoietic Cell TransplantRecruitingNCT06996119Phase 1
- Oral Tacrolimus vs Dexamethasone Micro-pulse Therapy in Pediatric Rapidly Progressing Vitiligo: A Multicenter RCTRecruitingNCT06900777Not applicable
- The Effect of 0.1% Topical Ciclosporin A for 12-weeks on the Eye Surface Immune Cells in Dry EyesRecruitingNCT06898853Not applicable
- COMPARISON OF EFFICACY AND SAFETY OF NARROWBAND UVB WITH 0.1% TACROLIMUS VS NARROWBAND UVB WITH 0.005% CALCIPOTRIOL IN TREATMENT OF VITILIGOEnrolling by invitationNCT06880042Early Phase 1
- Allo HSCT for High Risk HemoglobinopathiesRecruitingNCT06872333Phase 2
- Early Use of Tacrolimus in HLA-Mismatched Haploidentical Allogeneic Hematopoietic Transplantation With Post-Transplant CyclophosphamideRecruitingNCT06828796Phase 2
- Vedolizumab Plus Post-transplant Cyclophosphamide and Short Course Tacrolimus for the Prevention of Graft Versus Host Disease in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation After Reduced Intensity ConditioningRecruitingNCT06815003Phase 2
- Optimized Cord Blood Transplantation for the Treatment of Patients With High-risk Hematologic Malignancies Who Have Relapsed After First Allogeneic Stem Cell TransplantationRecruitingNCT06807606Phase 2
- Efficacy and Safety of Sirolimus With or Without Cyclosporin A in Chinese Patients With Aplastic Anemia Refractory/Intolerant to Cyclosporin ARecruitingNCT06802055Phase 2
- TRACK-TBI Precision Medicine Part 3 - Option IIEnrolling by invitationNCT06790095Phase 2
- A Study of the Efficacy and Safety of Cyclosporin Ophthalmic Gel in Subjects With Moderate to Severe Dry Eye DiseaseRecruitingNCT06766357Phase 3
- Neurocognitive Function Changes With Extended-Release Tacrolimus Among Older Kidney Transplant RecipientsRecruitingNCT06751992Phase 4
- Effectiveness and Cost-effectiveness of a Pre-emptive Genotyping Strategy in Patients Receiving TacrolimusRecruitingNCT06701825Phase 4
- Trial of Cell Based Therapy for DMDRecruitingNCT06692426Phase 1
- Fungal Ulcer Treatment Augmented With Natamycin and Cyclosporine ARecruitingNCT06658002Phase 3
- Utilising Genotype Informed Bayesian Dosing of Tacrolimus in Children Post Solid Organ Transplantation.RecruitingNCT06529536Phase 4
- Efficacy and Safety of Tacrolimus in Combination With Ripertamab in the Initial Treatment of Patients With MCDNot yet recruitingNCT06405100Phase 3
- Topical Tacrolimus for Breast Cancer-related LymphedemaEnrolling by invitationNCT06306274Phase 2/3
- Tacrolimus C:D Ratio Measured in Renal Transplant Recipients Treated With Once-daily Prolonged-release DrugsRecruitingNCT06268769Phase 4
- Tacrolimus Minimization in Kidney Transplant Recipients Selected According to the AGORA Algorithm for Their Low Immunological Risk and Medium-term Graft FailureRecruitingNCT06235892Phase 3
- Botox Versus Tacrolimus in Psoriasis VulgarisNot yet recruitingNCT06203470Phase 4
- Ruxolitinib With Tacrolimus and Methotrexate for the Prevention of Graft Versus Host Disease in Pediatric and Young Adult Patients Undergoing Allogeneic Hematopoietic Cell Transplant for Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Myelodysplastic SyndromeRecruitingNCT06128070Phase 2
- Intestinal & Multivisceral Transplantation for Unresectable Mucinous Carcinoma Peritonei (TRANSCAPE)Not yet recruitingNCT06084780Phase 2
- Pharmacokinetics, Effectiveness and Tolerability of Prolonged-release Tacrolimus After Paediatric Kidney TransplantationRecruitingNCT06057545Phase 3
- Advancing Transplantation Outcomes in ChildrenRecruitingNCT06055608Phase 2
- Cyclosporine In Takotsubo SyndromeRecruitingNCT05946772Phase 2
- Effectiveness of Mycophenolate Mofetil Combined With Tacrolimus for Steroid Tapering in Systemic Lupus ErythematosusRecruitingNCT05916781Phase 4
- Feasibility Pilot Sequential Multiple Assignment Randomized Trial (SMART) for Acute Severe Ulcerative ColitisRecruitingNCT05867329Phase 4
- Clinical Study of UCB Combined With UC-MSCs in the Treatment of Bone Marrow Failure DisordersRecruitingNCT05794425Phase 1/2
- A Study of Immune Suppression Treatment for People With Sickle Cell Disease or β-Thalassemia Who Are Going to Receive an Allogeneic Hematopoietic Cell Transplantation (HCT)RecruitingNCT05736419Phase 2
- Effect of Obesity on Cyclosporine Blood Trough Level in Nephrotic Syndrome PatientsRecruitingNCT05696977Phase 4
- Conversion of Maintenance Prograf to Envarsus in Liver Transplant RecipientsEnrolling by invitationNCT05655273Phase 4
- Uterus Transplantation to Treat InfertilityRecruitingNCT05646992Phase 2/3
- Combined Steroid and Cyclosporin as First-line Treatment in Adults With Primary Immune ThrombocytopeniaNot yet recruitingNCT05459649Phase 2
- Allogeneic Hematopoietic Stem Cell Transplantation for 4/M NeuroblastomaNot yet recruitingNCT05303727Phase 2
- Rectal Indomethacin and Oral Tacrolimus Versus Combination to Prevent Post-ERCP PancreatitisRecruitingNCT05252754Phase 3
- Tacrolimus Associated Tremors in Liver Transplantation: Immediate-Release Versus Extended-Release FormulationsRecruitingNCT05089604Phase 4
- Second-line Treatment of Primary Autoimmune Hemolytic AnemiaRecruitingNCT05057468Phase 3
- Trial Comparing Immediate Versus Extended Release Tacrolimus; Reducing Calcineurin Inhibitor Related Toxicity in Lung Transplantation PatientsRecruitingNCT05001074Phase 3
- Methods of T Cell Depletion Trial (MoTD)RecruitingNCT04888741Phase 2
- Cord Blood Transplant in Children and Young Adults With Blood Cancers and Non-malignant DisordersRecruitingNCT04644016Phase 2
- Early Use of Long-acting Tacrolimus in Lung Transplant RecipientsRecruitingNCT04469842Early Phase 1
- Early Initiation of Oral Therapy With Cyclosporine and Eltrombopag for Treatment Naive Severe Aplastic Anemia (SAA)RecruitingNCT04304820Phase 2Results posted
- Motor Neurone Disease - Systematic Multi-Arm Adaptive Randomised TrialRecruitingNCT04302870Phase 2/3
- BMT-06: Study of Intensity Modulated Total Marrow Irradiation (IM-TMI)RecruitingNCT04187105Phase 2
- Tacrolimus for the Treatment of Superficial Kaposiform Hemangioendothelioma and Tufted AngiomaRecruitingNCT04056962Phase 2
- CIRTEN-Simultaneous Pancreas-Kidney Transplant RecipientsRecruitingNCT03769298Phase 2/3
- Impact of Envarsus XR® on Kidney Biopsy Subclinical Rejection and Blood Immunologic ProfileRecruitingNCT03321656Phase 2/3
- The Effect and Safety Profile of Thymoglobulin® in Primary Cardiac Transplant RecipientsEnrolling by invitationNCT03292861Phase 2
- A Study of Patient Adherence and Convenience to Immunosuppressive Agents in Newly Liver TransplantRecruitingNCT03216447Phase 4
- 211^At-BC8-B10 Before Donor Stem Cell Transplant in Treating Patients With High-Risk Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndrome, or Mixed-Phenotype Acute LeukemiaRecruitingNCT03128034Phase 1/2
- Study to Improve OS in 18 to 60 Year-old Patients, Comparing Daunorubicin Versus High Dose Idarubicin Induction Regimens, High Dose Versus Intermediate Dose Cytarabine Consolidation Regimens, and Standard Versus MMF Prophylaxis of GvHD in Allografted Patients in First CRRecruitingNCT02416388Phase 2/3
- Human Penile AllotransplantationRecruitingNCT02395497Phase 2/3
- Effects of Treatment With Biological Agents on Vascular and Cardiac Function in PsoriasisRecruitingNCT02144857Phase 4
- Allogeneic Hematopoietic Stem Cell Transplant for GATA2 MutationsRecruitingNCT01861106Phase 2
- Reduced Intensity Haploidentical BMT for High Risk Solid TumorsRecruitingNCT01804634Phase 2
- Methylprednisolone, Horse Anti-Thymocyte Globulin, Cyclosporine, Filgrastim, and/or Pegfilgrastim or Pegfilgrastim Biosimilar in Treating Patients With Aplastic Anemia or Low or Intermediate-Risk Myelodysplastic SyndromeRecruitingNCT01624805Phase 2
- Rituximab Plus Cyclosporine in Idiopathic Membranous NephropathyRecruitingNCT00977977Phase 2
- A Clinical Trial to Evaluate the Corneal Endothelial Health of DED Subjects Treated With CyclosporineCompletedNCT06329661Phase 4Results posted
- Pediatric Study of GVHD Ppx w/o Calcineurin Inhibitors After Day60 Post First Allo HSCT for Hematological Malignancies.TerminatedNCT05579769Phase 2Results posted
- A Drug Interaction Study of Cyclosporine and LY3502970 in Healthy ParticipantsCompletedNCT05573230Phase 1Results posted
- Off-the-shelf NK Cells + SCT for Myeloid MalignanciesCompletedNCT05115630Phase 2Results posted
- COVID Protection After Transplant-Immunosuppression ReductionCompletedNCT05077254Phase 2Results posted
- Novel Use of Cyclosporine Ophthalmic Emulsion 0.05% in a PROSE DeviceCompletedNCT04918823Phase 1/2Results posted
- Study to Assess the Effect of Sodium Zirconium Cyclosilicate on the Pharmacokinetics of Tacrolimus and Cyclosporin in Healthy SubjectsCompletedNCT04788641Phase 1Results posted
- Bioequivalence Study of Tacrolimus in Healthy VolunteersCompletedNCT04725682Phase 1Results posted
- Pharmacokinetics of Verinurad and Allopurinol in Combination With Cyclosporine and Rifampicin in Healthy VolunteersCompletedNCT04532918Phase 1Results posted
- Donor Stem Cell Transplant After Chemotherapy for the Treatment of Recurrent or Refractory High-Risk Solid Tumors in Pediatric and Adolescent-Young AdultsTerminatedNCT04530487Phase 2Results posted
- Cyclosporine For The Treatment Of COVID-19(+)CompletedNCT04492891Phase 2Results posted
- Envarsus XR in Lung TransplantCompletedNCT04420195Phase 2Results posted
- Itacitinib, Tacrolimus, and Sirolimus for the Prevention of GVHD in Patients With Acute Leukemia, Myelodysplastic Syndrome, or Myelofibrosis Undergoing Reduced Intensity Conditioning Donor Stem Cell TransplantationCompletedNCT04339101Phase 2Results posted
- Combination of Eltrombopag With Immunosuppressive Therapy in East-Asian Patients With Severe Aplastic AnemiaCompletedNCT04328727Phase 2Results posted
- Reduce Intensity Conditioning Donor Stem Cell Transplant for the Treatment of Relapsed Multiple MyelomaTerminatedNCT04205240Phase 2Results posted
- A Safety Study of Liposomal Cyclosporine A to Treat Bronchiolitis After Hematopoietic Transplant (BOSTON-4)TerminatedNCT04107675Phase 2Results posted
- Use of Sublingual Tacrolimus in Adult Blood and Marrow Transplant PatientsCompletedNCT04041219Phase 4Results posted